News

IASLC Announces New Global Initiative to Create Patient/Provider Information System

LCAM 2015 Header

Contact:  Jeff Wolf                                                                                           Becky Bunn                                      
IASLC Director of Communications                                                             IASLC Projects Specialist             
Jeff.Wolf@IASLC.org | 720-325-2952                                                        Becky.Bunn@IASLC.org | 720-325-2946                                                                                                

 

IASLC Announces New Global Initiative to Create Patient/Provider Information System
Cards Will Improve Communication & Comprehension

DENVER – As part of Lung Cancer Awareness Month in November, the International Association for the Study of Lung Cancer (IASLC) today announced a new global initiative to create a set of Patient/Provider Lung Cancer Information Cards to create better communication and understanding between physicians, patients and their families with the goal of improving collaboration and better treatment outcomes around the world.

Lung cancer is the leading cause of cancer-related deaths throughout the world. Every year, lung cancer causes more than 1.6 million deaths; more than breast, colon and prostate cancers combined. Because of the nature of the disease, health professionals often diagnose it late, making it more difficult to treat and increasing the urgency for an aggressive treatment plan. The more informed doctors are of the options for lung cancer patients, and the more patients know the questions to ask, the better (and faster) treatment decisions can be made.

Lung cancer research and treatments continue to progress very quickly, leaving many doctors and other health professionals unaware of new and effective lung cancer treatments. In addition, doctors often express concern over how to discuss smoking cessation with patients during their diagnosis or while they undergo cancer treatment. Patients and advocates express concern that health professionals do not always present them with certain options, including molecular testing of their tumor, some newer treatment options or information about clinical trials and whether or not they are eligible. Patients also often suggest that health professionals can handle these situations in more compassionate and productive ways. 

“The IASLC is known as a global leader in bridging the gap between patients and their doctors. We understand the importance of sharing best practices and it is our goal to improve patients’ experiences and outcomes and to give doctors another tool in the fight against lung cancer,” said Dr. Fred R. Hirsch, Professor of Medicine and Pathology at the University of Colorado Cancer Center and School of Medicine and CEO of the IASLC.

The Patient/Provider Lung Cancer Information Cards will contain information for patients and their families, as well as information for physicians and other health professionals.

“This is something that I as a patient would have found very helpful to both me and my doctor. It gives us both ways to open up new conversations and I hope that it will act as a source of comfort for all of those involved in the fight for survival,” said Janet Freeman-Daily, a lung cancer survivor and patient advocate.

Cards will also be printed in multiple languages, including Chinese, Japanese and Spanish, using graphics to help clarify the message. 

“We will never stop in our efforts to better inform doctors and patients around the world about lung cancer treatment options, with the goal of eradicating this disease,” said Dr. Hirsch. “These cards exemplify the foresight and the international reach of the IASLC as we lead the fight against thoracic cancers.”

A team of IASLC leaders, staff and members will work to create this new tool for those working together to battle lung cancer over the next year and IASLC aims to release the Patient/Provider Lung Cancer Information Cards for Lung Cancer Awareness Month in 2016. The committee is made up of members of many different advocacy organizations from around the world. They believe these new cards can make the most impact by influencing providers and patients at the time of patient interaction with up-to-date information about lung cancer screening, diagnosis and treatment.

For more information on Lung Cancer Awareness Month, please visit www.iaslc.org/lcam and read our lung cancer fact sheets which provide crucial information about the disease and the work to conquer it worldwide. We also have experts from around the globe ready to discuss a variety of topics, including personalized medicine, tobacco control, prevention, lung cancer screening and patient advocacy. Please reach out to the IASLC through Director of Communications Jeff Wolf or Projects Specialist Becky Bunn.


About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization specifically dedicated to the study of lung cancer. Founded in 1974, the association's membership includes nearly 4,000 lung cancer specialists in 80 countries. For more information, visit:  https://www.iaslc.org/.

 

###

November 18, 2015